Novel Indoline Derivatives Serotonergic Psychedelic Agents as 5‑HT2A Agonists for Treating Psychosis, Mental Illness and CNS Disorders. [PDF]
Sabnis RW, Sabnis AR.
europepmc +1 more source
A randomised placebo-controlled study of the effects of lysergic acid diethylamide microdosing (15 μg) on pain perception in healthy volunteers. [PDF]
Cavarra M +9 more
europepmc +1 more source
Simple Analogs of the LSD D-Ring: A Consideration of Structure-Activity Relationships and Their Potential as Therapeutics. [PDF]
Barker SA.
europepmc +1 more source
Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems. [PDF]
Zhang T, Lin C, Wang X.
europepmc +1 more source
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. [PDF]
Dos Santos RG +5 more
europepmc +1 more source
Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics. [PDF]
Bhat A +6 more
europepmc +1 more source
The renaissance of research on psychedelics in child and adolescent psychopharmacology. [PDF]
Crocq MA, Auby P.
europepmc +1 more source
Psychedelics as Novel Therapeutics for Chronic Pain in Veterinary Medicine: A Hypothesis-Driven Protocol Using Low-Dose 1-Cyclopropionyl-D-lysergic Acid Diethylamide (1cp-LSD) in Canine Osteoarthritis. [PDF]
Hernández-Álvarez E +3 more
europepmc +1 more source
Psychedelics, the media portrayal and large-language model evaluations. [PDF]
Clelland CL.
europepmc +1 more source
Prevalence and predictors of sexual and physical violence during psychedelic use in a US population-based study. [PDF]
Chwyl C +6 more
europepmc +1 more source

